(19)
(11) EP 1 586 566 B9

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)
Corrections, see
Description

(48) Corrigendum issued on:
18.11.2009 Bulletin 2009/47

(45) Mention of the grant of the patent:
13.05.2009 Bulletin 2009/20

(21) Application number: 05006473.2

(22) Date of filing: 24.03.2005
(51) International Patent Classification (IPC): 
C07D 251/46(2006.01)

(54)

P-toluenosulfonate salt of N-Methyl-N-(3,5-dimathoxy-2,4,6-triazinyl-1-)-morpholine and related compounds for use as condensing reagent in peptide synthesis

P-Toluenosulfonatsalz des N-Methyl-N-(3,5-dimatoxy-2,4,6-triazinyl-1-)-Morpholins und verwandte Verbindungen zur Verwendung als Kondensationsreagenz in der Peptidsynthese

Sél P-toluenosulfonate de la N-méthyle-N-(3,5-dimatoxy-2,4,6-triazinyl-1-)-morpholine et composés similaires pour l'utilisation comme réagents de condensation dans la synthèse de peptides


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 29.03.2004 PL 36667304

(43) Date of publication of application:
19.10.2005 Bulletin 2005/42

(73) Proprietors:
  • Politechnika Lodzka
    90-924 Lodz (PL)
  • Kaminski, Zbigniew
    94-050 Lodz (PL)
  • Kolesinska, Beata
    93-530 Lodz (PL)

(72) Inventors:
  • Kaminski, Zbigniew
    94-050 Lodz (PL)
  • Kolesinska, Beata
    93-530 Lodz (PL)
  • Kolesinska, Justyna
    93-530 Lodz (PL)
  • Jastrzabek, Konrad
    94-058 Lodz (PL)

(74) Representative: Balczewski, Zbigniew Wojciech 
Osrodek Wynalazczosci Politechniki Lodzkiej ul. Zeromskiego 116
PL-90-924 Lodz
PL-90-924 Lodz (PL)


(56) References cited: : 
WO-A-01/96282
   
  • KUNISHIMA ET AL: "Approach to green chemistry of DMT-MM: recovery and recycle of coproduct to chloromethane-free DMT-MM" TETRAHEDRON LETTERS, vol. 43, no. 18, 2002, pages 3323-3326, XP002338627
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).


Description


[0001] The object-matter of the invention are new compounds, N-triazinylammonium salts and application of the new compounds.

[0002] Chlortriazynes and N-triazinylammonium salts of hydrochloric , fluoroboric, fluorophosphoric and perchloric acids are known among other from professional journals like Biopolymers, 55 (2) 140-165 and Australian Journal of Chemical Society, 54, 469 (2001) as well as from numerous patent specifications. The above mentioned triazyn compounds, as well as carbodiimides, uronium salts, guanidine salts and phosphonium derivatives of benzotriazole or of azobenzotriazole are currently the most often used condensing reagents in production of nucleic acids, peptides, amides, esters and carboxylic acid anhydrides, in reactions of hydrogenation carboxylic functional groups to aldehyde groups as well as reagents used for protection of functional groups. However, they have some inconveniences. Namely, chlorotriazines and triazinylammonium chlorides are susceptible to dealkilation in presence of strong nucleophilic chloride anion. Triazinylammonium salts of fluoroboric and fluorophosphoric acids pollute the environment. Carbodiimides are susceptible to migration of the acyl group O->N, develop allergic reactions and processes in which they are involved are often low effective. The uronium, guanidinium and phosphonium salts are hardly available due to high production costs, with exception of uronium salts ofN-oxide of 2-mercapto-pyridone which are more easily available but their application is limited due to presence of strong nucleophilic sulfur atom, which develops many side reactions.

[0003] The invention refers to quarternary N-(3,5-disubstituted-2,4,6-triazinyl-1)ammonium salts of sulfonic acids, of the formula 1,

where R1 and R2 denote independently of each other a halogen atom, an alkyl group, a substituted alkyl group, an alkoxy group, a substituted alkoxy group, a cycloalkoxy group, a substituted cycloalkoxy group, an aryl group, a substituted aryl group, an aryloxy group, a substituted aryloxy group, a heterocyclic group or a substituted heterocyclic group, R3, R4, R5 denote independently of each other an alkyl group, a substituted alkyl group, a cycloalkyl group, a substituted cycloalkyl group, an aryl group, a substituted aryl group, a heterocyclic group or a substituted heterocyclic group, or form an unsubstituted heterocyclic ring together with the nitrogen atom, whereas -O-SO2R6 denotes a benzenosulfonate anion, a p-toluenosulfonate anion, a p-bromobenzenosulfonate anion, a p-chlorobenzenosulfonate anion, a methanosulfonate anion or an amidosulfonate anion. The R1 and R2 denote the methoxy group.

[0004] The new compounds of the formula 1 are designed as condensing reagents in the synthesis of amides, esters, carboxylic acid anhydrides, peptides and peptide esters.

[0005] The new compounds of the formula 1 are formed in reaction of sulfonic acids salts of the formula 2,

where -O-SO2R6 denotes the above specified groups, preferable of lithium or silver salts, with quarternary triazinylammonium chlorides or by simultaneous reactions of sulfonic acids salts of the formula 2, with 2-chloro-4,6-disubstituted-1,3,5-triazine, preferable with 2-chloro-4,6-dimethoxy-1,3,5-triazine and tertiary amines.

[0006] The new compounds are more easily available and less expensive as compared to the known triazinylammonium salts, and their anions (sulfonic) are not toxic and readily biodegradable, therefore safe for the natural environment. Moreover, these compounds are considerable more resistant to dealkylation, than other known triazinylammonium salts, providing very good results of condensation, as compared to other commonly used condensating reagents.

[0007] The object-matter of the invention is illustrated by following examples, which will not limit of its range.

Example I.



[0008] Mixture of 17.8 g (100 mmol) of lithium p-toluenosulfonate and 27.6 g (100 mmol) of N-methyl-N-(3,5-dimethoxy -2,4,6-triazinylo-1)morpholine chloride in 100 ml acetonitrile was cooled down to a temperature approximating to 5°C and intensively stirred for 3 hours, next the precipitate was separated by filtration. The precipitate was two times washed with acetonitrile and the collected filtrates were evaporated to dryness under reduced pressure. Dry residue was washed with 50 ml tetrahydrofurane and crystallized from acetonitrile. It was obtained 31.7 g p-toluenosulfonate of N-methyl-N-(3,5-dimethoxy-2,4,6--triazinyl-1-)-morpholine, what equals to 77% yield. The new compound was characterized with the following data:
melting point = 59 - 60 °C,
Results of elementary analysis of the formula : C17H24N4O6S (412.47)
calculated: %C 49.50, %H 5.87, %N 13.58, %S 7.77
found: %C 48.67, %H 5.54, %N 13.61, %S 7.63.

Example II.



[0009] Mixture of 17.8 g (100 mmol) of lithium p-toluenosulfonate and 100 ml acetonitrile was cooled down to a temperature approximating to 0°C and, intensively stirring, simultaneously added dropwise 50 ml of solution of 17.6 g (100 mmol) 2-chloro-4,6-dimethoxy-1,3,5-triazine in acetonitrile and 11 ml (100 mmol) of N-methylomorpholine. The stirring of the mixture was continued at a temperature of 0°C for 2 hours, next the precipitate was separated by filtration. The precipitate was washed with 3 portions by 30 ml of acetonitrile and the collected filtrates were evaporated to dryness. The residue was washed with 25 ml tetrahydrofurane and crystallized from acetonitrile.

[0010] It was obtained 30.6 g p-toluenosulfonate of N-methyl-N-(3,5-dimethoxy-2,4,6-triazinyl-1-)--morpholine, what equals to 74% yield. The new compound was characterized with the following data:
melting point = 59 - 60 °C,
Results of elementary analysis of the formula: C17H24N4O6S
calculated: %C 49.50, %H 5.87, %N 13.58, %S 7.77
found: %C 48.79, %H 5.48, %N 13.49, %S 7.55.

Example III.



[0011] 23,8 g (100 mmol) of lithium 10-camphorosulfonate and 80 ml acetonitrile was cooled down to a temperature approximating to 5°C and, intensively stirring, simultaneously added dropwise the solution of 17.6 g (100 mmol) of 2-chloro-4,6-dimethoxy-1,3,5-triazine in 50 ml acetonitrile and simultaneously 11 ml (100 mmol) N-methylmorpholine. The stirring of the mixture was continued at a temperature of 0°C for 2 hours, next the precipitate was separated by filtration. The precipitate was washed with acetonitrile (3 x 30 ml) and the collected filtrates were evaporated to dryness. The residue was washed with tetrahydrofurane (25 ml) and crystallized from acetonitrile.
It was obtained 28.4 g of 10-camphorosulfonate of N-methyl-N-(3,5-dimethoxy-2,4,6-triazinyl-1-)-morpholine, what equals to 60% yield.
The new compound was characterized with the following data:
Melting point =127-129°C,
Results of elementary analysis of the formula: C20H32N4O7S (472,56)
calculated: %C 50.83, % H 6.83, % N 11.86, % S 6.79
found: % C 48.84, % H 6.83 % N 13.18, % S 5.48.

Example IV.



[0012] To a mixture of 17.8 g (100 mmol) of lithium p-toluenosulfonate in 30 ml acetonitrile, cooled down to a temperature approximating to 0°C, simultaneously added drop by drop solution of 1.76 g (10 mmol) CDMT in 20 ml of acetonitrile and solution of 1.11 g (10 mmol) of quinuclidine in 5 ml acetonitrile. Then, the stirring of the mixture was continued at a temperature of 0°C for 2 hours, next the precipitate was separated by filtration. The precipitate was washed with 2 portions by 25 ml acetonitrile and the collected filtrates were evaporated to dryness. The residue was washed with ethyl ether and crystallized from acetonitrile.
It was obtained 2.95 g of p-toluensulfonate of N-(3,5-dimethoxy-2,4,6-triazinyl-1-)-quinuclidine in the form of thick oily liquid, what equals to 70% yield. The new compound was characterized with the following data:
Results of elementary analysis of the formula: C19H26N4O5S (422.51)
calculated: %C 54.01; %H 6.20; %N 13.26; %S 7.59
found: %C 54.04; %H 6.16, %N 13.38, %S 7.22.

Example V.



[0013] To an intensively stirred mixture of 1.02 g (10 mmol) of lithium methansulfonate in 30 ml acetonitrile, cooled down to a temperature approximating to 0°C, simultaneously added drop by drop a solution of 1.75 g (10 mmol) CDMT in acetonitrile and solution of 1.1 g (10 mmol) of N-methylmorpholine in 5 ml acetonitrile. Then, the stirring of the mixture was continued at a temperature of 0°C for 2 hours, next the precipitate was separated by filtration. The precipitate was washed with 2 portions by 25 ml acetonitrile and the collected filtrates were evaporated to dryness. The residue was washed with ethyl ether, dried and crystallized from acetonitrile.
It was obtained 0.185 g methansulfonate of N-methyl-N-(3,5-dimethoxy-2,4,6-triazinyl-1-)--morpholine, what equals to 55 % yield. The new compound was characterized with the following data:
Melting point: 96 - 98°C
Results of elementary analysis of the formula C11H20N4O6S (336,37):
calculated: %C 39.28 %H 5,99 %N 16.66 %S 9.53,
found: %C 37.45 %H 6.14 %N 16.20 %S 8.61.

Example VI.



[0014] 0,4125 g (1 mmol) p-toluenesulfonate of N-methyl-N-(3,5-dimethoxy-2,4,6-triazinyl-1)-morpholine was dissolved in 5 ml acetonitrile and added 0.3294 g (1mmol) Fmoc-AlaOH, next the mixture was cooled down in an ice/water bath and added 0.110 ml (1 mmol) of NMM. After 2 hours, to the intensively cooled and stirred mixture 0.1817 g (1 mmol) H-Leu-OMe x HCl and 0.110 ml (1 mmol) NMM was added. The mixture was left for 12 hours at room temperature, then acetonitrile was removed in a vacuum evaporator. The residue was dissolved in 5 ml of ethyl acetate and washed one by one with water, NaHSO4, water, NaHCO3 and again with water, the organic layer was dried over MgSO4, then the drying agent was removed by filtration and the solvent was evaporated to dryness.
It was obtained 0.3815 g of Fmoc-Ala-Leu-OMe dipeptide, what equals to 87% yield. The NMR analysis gave following results:
1H-NMR (CDCl3):δ = 0,88 (d, 6H, J = 15 Hz, (CH3)2-CH-), 1,30 (d, 3H, J=12 Hz, CH3CH-), 1,48-1,67 (m, 2H, (CH3)2CHCH2-), 3,63 (s, 3H, CH3O-), 4,02 (t, 1H, J=6 Hz, -CHCH2O-), 4,18 (d, 2H, J=9,5 Hz, -CHCH2O), 4,32 (q, 1H, J=5 Hz, (CH3)2CHCH2-), 4,50 (qu, 1H, CH3CH-), 7,08-7,66 (8H, arom) [ppm].

Example VII.



[0015] 0,423 g (1 mmol) p-toluenesulfonate of N-(3,5-dimdthoxy-2,4,6-triazinyl-1-)-quinuclidine was dissolved in 5 ml acetonitrile and added 0.3294 g (1mmol) Fmoc-Ala-OH, next the mixture was cooled down in an ice/water bath and added 0.110 ml (1 mmol) of NMM. After 2 hours, to the intensively cooled and stirred mixture 0.1396 g (1 mmol) H-Ala-OMe x HCl and 0.110 ml (1 mmol) NMM was added. The mixture was left for 12 hours at room temperature, and then acetonitrile was removed in a vacuum evaporator. The residue was dissolved in 5 ml of ethyl acetate and washed one by one with water, NaHSO4, water, NaHCO3 and again with water. The organic layer was dried over MgSO4, then the drying agent was removed by filtration and the solvent was evaporated to dryness.
It was obtained 0.3608 g of Fmoc-Ala-Ala-OMe dipeptide, what equals to 91% yield. The NMR analysis of the dipeptide gave following results:
1H-NMR (CDCl3):δ = 1,23 (d, 3H, J = 12 Hz, CH3-CH-), 1,32 (d, 3H, J=12 Hz, CH3CH-), 3,61 (s, 3H, CH3O-), 3,99-4,04 (m, 2H, -CHCH2O- i -COCHCH3), 4,18 (d, 2H, J=9,5 Hz, -CHCH2O), 4,49 (qu, 1H, CH3CH-), 7,08-7,72 (8H, arom) [ppm].

Example VIII.



[0016] 0,4125 g (1 mmole) p-toluenesulfonate of N-methyl-N-(3,5-dimethoxy-2,4,6-triazinyl-1-)--morpholine was dissolved in 5 ml acetonitrile and added 0.3294 g (1mmol) Fmoc-Ala-OH, next the mixture was cooled down in an ice/water bath and added 0.110 ml (1 mmol) of NMM. After 2 hours, to the intensively cooled and stirred mixture 0.2157 g (1 mmole) H-Phe-OMe x HCl and 0.110 ml (1 mmole) NMM was added. The mixture was left for 12 hours at room temperature, then acetonitrile was removed in a vacuum evaporator. The residue was dissolved in 5 ml of ethyl acetate and washed one by one with water, NaHSO4, water, NaHCO3 and again with water. The organic layer was dried over MgSO4, then the drying agent was removed by filtration and the solvent was evaporated to dryness. It was obtained 0.4158 g of Fmoc-Ala-Phe-OMe dipeptide, what equals to 88% yield. The NMR analysis of the dipeptide gave following results:
1H-NMR (CDCl3):δ = 1,30 (d, 3H, J = 12 Hz, CH3-CH-), 3,06-3,08 (m, 2H, -CH2-C6H5), 3,55 (s, 3H, CH3O-), 4,04 (t, 1H, J= 6,5 Hz, -CHCH2O-), 4,18 (d, 2H, J=9,5 Hz, -CHCH2O), 4,47 (qu, 1H, J=6,5 Hz, CH3CH-), 4,86 (q, 1H, J=7 Hz, -CH-CH2-), 7,08-7,72 (13H, arom) [ppm].

Example IX.



[0017] 0,4125 g (1 mmol) p-toluenesulfonate of N-methyl-N-(3,5-dimethoxy-2,4,6-triazinyl-1-)--morpholine was dissolved in 5 ml acetonitrile and added 0.2373 g (1mmol) Z-Aib-OH, next the mixture was cooled down in an ice/water bath and added 0.110 ml (1 mmol) ofNMM. After 2 hours, to the intensively cooled and stirred mixture 0.1396 g (1 mmol) H-Ala-OMe x HCl and 0.110 ml (1 mmol) NMM was added. The mixture was left for 12 hours at room temperature. Then, acetonitrile was removed in a vacuum evaporator. The residue was dissolved in 5 ml of ethyl acetate and washed one by one with water, NaHSO4, water, NaHCO3 and again with water. The organic layer was dried over MgSO4, then the drying agent was removed by filtration and the solvent was evaporated to dryness.
It was obtained 0.2741 g of Z-Aib-Ala-OMe dipeptide, what equals to 85% yield.
1H-NMR (CDCl3):δ = 1,33 (d, 3H, J = 10 Hz, CH3-CH-), 1,49 (s, 6H, (CH3)2C-), 3,62 (s, 3H, CH3O-), 4,46 (qu, 1H, CH3CH-), 5,06 (AB system, 2H, J= 8,5 Hz, -CH2O-), 7,28-7,36 (5H, arom) [ppm].

Example X.



[0018] 0.473 g (1 mmol) of N-methyl-N-(3,5-dimethoxy-2,4,6-triazinyl-1-)-morpholine 10--camphorsulfonate was dissolved in 5 ml acetonitrile, 0.2373 g (1 mmol) Z-Aib-OH was added, then the reaction mixture was cooled down on an ice/water bath and 0.110 ml (1 mmole) NMM was added. After 2 hours, to the intensively cooled and stirred mixture 0.2157 g (1 mmole) H-Phe-OMe XHCl and 0.110 ml (1 mmole) NMM were added. The mixture was left at room temperature for 12 hours. Next, acetonitrile was removed in a vacuum evaporator, and the residue was dissolved in 5 ml of ethyl acetate and washed successively with water, NaHSO4, water, NaHCO3 and again with water. The organic layer was dried over MgSO4, then the drying agent was removed by filtration and the solvent was evaporated to dryness.
It was obtained 0.3227 g of Z-Aib-Phe-OMe dipeptide, what equals to 81% yield.
The NMR analysis of the dipeptide gave following results:
1H-NMR (CDCl3):δ = 1,50 (s, 6H, (CH3)2C-), 3,08-3,10 (m, 2H, -CH2CH-), 3,59 (s, 3H, CH3O-), 4,85-4,89 (m, 1H, -CH2CH-), 5,06 (AB system, 2H, J = 8,5 Hz, -CH2O-), 7,26-7,37 (10H, arom) [ppm].

Example XI.



[0019] 0,4125 g (1 mmol) p-toluenesulfonate of N-methyl-N-(3,5-dimethoxy-2,4,6-triazinyl-1-)--morpholine was dissolved in 5 ml acetonitrile and added 0.2373 g (1mmol) Z-Aib-OH, next the mixture was cooled down in an ice/water bath and added 0.110 ml (1 mmol) of NMM After 2 hours, to the intensively cooled and stirred mixture 0.1817 g (1 mmol) H-Leu-OMe x HCl and 0.110 ml (1 mmol) NMM was added. The mixture was left for 12 hours at room temperature. Then, acetonitrile was removed in a vacuum evaporator. The residue was dissolved in 5 ml of ethyl acetate and washed one by one with water, NaHSO4, water, NaHCO3 and again with water. The organic layer was dried over MgSO4, then the drying agent was removed by filtration and the solvent was evaporated to dryness.
It was obtained 0.3062 g of Z-Aib-Leu-OMe dipeptide, what equals to 84% yield.
1H-NMR (CDCl3):δ = 0,86 (d, 6H, J = 8,5 Hz, (CH3)2-CH-), 1,46-1,68 (m, 2H, -CH2CH-), 1,50 (s, 6H, (CH3)2C-), 3,63 (s, 3H, CH3O-), 4,28 (q, 1H, -CH2CH-), 5,06 (AB system, 2H, J = 8,5 Hz, -CH2O-), 7,29-7,34 (5H, arom) [ppm].

Example XII.



[0020] 0,4125 g (1 mmol) p-toluenesulfonate of N-methyl-N-(3,5-dimethoxy-2,4,6-triazinyl-1-)-morpholine was dissolved in 5 ml acetonitrile and added 0.3664 g (1mmole) Boc-Orn(Z) -OH, next the mixture was cooled down in an ice/water bath and added 0.110 ml (1 mmole) of NMM After 2 hours, to the intensively cooled and stirred mixture 0. 1817 g (1 mmole) H-Leu-OMe x HCl and 0.110 ml (1 mmol) NMM was added. The mixture was left for 12 hours at room temperature. Then, acetonitrile was removed in a vacuum evaporator. The residue was dissolved in 5 ml of ethyl acetate and washed one by one with water, NaHSO4, water, NaHCO3 and again with water. The organic layer was dried over MgSO4, then the drying agent was removed by filtration and the solvent was evaporated to dryness.
It was obtained 0.4393 g of Boc-Orn(Z)-Leu-OMe dipeptide, what equals to 89% yield. The NMR analysis of the dipeptide gave following results:
1H-NMR (CDCl3):δ = 0,86 (d, 6H, J = 8,5 Hz, (CH3)2-CH-), 1,41-1,70 (m, 6H, -CH2CH- and -CH2CH2CH2CH-), 1,47 (s, 9H, (CH3)3C-), 3,37 (q, 2H, J= 4,5 Hz, -NH-CH2CH2CH2CH-), 3,63 (s, 3H, CH3O-), 3,93 (q, 1H, J=4,5 Hz, -CH2-CH-CONH-), 4,29 (q, 1H, J=4,0 Hz, -CONH-CH-CH2-), 5,06 (AB system, 2H, J = 8,5 Hz, -CH2O-), 7,35 (s, 5H, arom) [ppm].

Example XIII



[0021] 0,4125 g (1 mmol) p-toluenesulfonate of N-methyl-N-(3,5-dimethoxy-2,4,6-triazinyl-1-)-morpholine was dissolved in 5 ml acetonitrile and added 0.823 g (2 mmol) Fmoc-Asp(OtBu)-OH, next the mixture was cooled down in an ice/water bath and added 0.220 ml (2 mmol) of NMM. After 2 hours, to the intensively cooled and stirred mixture 0,386 g, (2 mmol) pentaflurophenol and 0.220 ml (2 mmol) NMM was added. The mixture was left for 12 hours at room temperature. Then, acetonitrile was removed in a vacuum evaporator. The residue was dissolved in 10 ml of ethyl acetate and washed one by one with water, NaHSO4, water, NaHCO3 and again with water. The organic layer was dried over MgSO4, then the drying agent was removed by filtration and the solvent was evaporated to dryness. It was obtained 1.016 g of pentafluorophenyl ester (Fmoc-Asp(OtBu)-OPfp), what equals to 88% yield.
The NMR analysis of the dipeptide gave following results:
1H-NMR (CDCl3):δ = 1,43 (s, 9H, (CH3)3CO-), 2,96 (ukl AB, 2H, J1 = 8 Hz, J2 = 12 Hz -OCOCH2CH-), 4,20-4,60 (m, 3H, -CHCH2OCONH-), 4,95 (dt, 1H, J=12 Hz, -OCOCH2CH-), 7,08=7,76 (m, 8H, arom.) [ppm].

Example XIV.



[0022] 0.825 g (2 mmol) of p-toluenosulfonate of N-methylo-N-(3,5-dimethoxy-2,4,6-triazinyl-1-) -morpholine, was dissolved in 10 ml acetonitrile, next 0.823 g (2 mmol) Fmoc-Asp(OtBu)--OH were added. Then, the mixture was cooled down on the ice/water bath and 0.220 ml (2 mmol) NMM were added. After 2 hours, to the intensively cooled an stirred suspension 0.2 ml (3 mmol) of allyl alcohol were added and the mixture was left at room temperature for 12 hours. Next, acetonitrile was removed in a vacuum evaporator, the residue was dissolved in 10 ml ethyl acetate and washed one by one with water, NaHSO4, water, NaHCO3 and again with water. The organic layer was dried over MgSO4, then the drying agent was removed by filtration and the solvent was evaporated to dryness.
It was obtained 0.777 g of allyl ester (Fmoc-Asp(OtBu)-OAll), what equals to 86% yield. The NMR analysis of the ester gave following results:
1H-NMR (CDCl3):δ = 1,43 (s, 9H, (CH3)3CO-), 2,86 (ukl AB, 2H, J1 = 7 Hz, J2 = 10 Hz -OCOCH2CH-), 4,08-4,39 (m, 3H, -CHCH2OCONH-), 4,65 (dt, 1H, J=12 Hz, -OCOCH2CH-), 4,71 (d, 2H, J = 6 Hz, -OCH2CHCH2), 5,27-5,35 (m, 2H, -OCH2CHCH2), 5,58-5,62 (m, 1H, -OCH2CHCH2), 7,08-7,75 (m, 8H, arom) [ppm].

Example XV.



[0023] 0,4125 g (1 mmol) p-toluenesulfonate of N-methyl-N-(3,5-dimethoxy-2,4,6-triazinyl-1-) morpholine was dissolved in 5 ml acetonitrile and added 0.346 g (1 mmole) Fmoc-Ala-OH, next the mixture was cooled down in an ice/water bath and added 0.110 ml (12 mmole) of NMM. After 2 hours, to the intensively cooled and stirred mixture 0,156 g, (1 mmole) natural menthol was added. The mixture was left for 12 hours at room temperature. Then, acetonitrile was removed in a vacuum evaporator. The residue was dissolved in 10 ml of ethyl acetate and washed one by one with water, NaHSO4, water, NaHCO3 and again with water. The organic layer was dried over MgSO4, then the drying agent was removed by filtration and the solvent was evaporated to dryness.
It was obtained 0.387 g of menthyl ester (Fmoc-Ala-O-menthol), what equals to 86% yield. The NMR analysis of the ester gave following results:
1H-NMR (CDCl3):δ = 0,81 (d, 3H, J = 12 Hz, CH3-CH-menthol), 1,23 (d, 6H, J=12 Hz, (CH3)2CH-), 1,42 (d, 3H, J = 10 Hz, CH3CH-), 1,06-2,09 (m, 8H, menthol), 3,75 (dq, 1H, O-CH-menthol), 4,35 (t, 1H, J=6 Hz, -CHCH2O-), 4,65 (d, 2H, J=9,5 Hz, -CHCH2O), 4,75 (qu, 1H, CH3CH-), 7,08-7,66 (8H, arom) [ppm].


Claims

1. Quaternary N-(3,5-disubstituted-2,4,6-triazinyl-1)-ammonium salts of sulfonic acids of the formula 1,

where R1 and R2 denote independently of each other a halogen atom, an alkyl group, a substituted alkyl group, an alkoxy group, a substituted alkoxy group, a cycloalkoxy group, a substituted cycloalkoxy group, an aryl group, a substituted aryl group, an aryloxy group, a substituted aryloxy group, a heterocyclic group or a substituted heterocyclic group, R3, R4, R5 denote independently of each other an alkyl group, a substituted alkyl group, a cycloalkyl group, a substituted cycloalkyl group, an aryl group, a substituted aryl group, a heterocyclic group or a substituted heterocyclic group or form an unsubstituted heterocyclic ring together with the nitrogen atom, whereas -O-SO2R6 denotes a benzenosulfonate anion, a p-toluenosulfonate anion, a p-bromobenzenosulfonate anion, a p-chlorobenzenosulfonate, anion, a methanosulfonate anion or an amidosulfonate anion.
 
2. The salts of the formula 1 as claimed in claim 1 characterized in that the R1 and R2 denote the methoxy group.
 
3. Use of the compounds of claim 1 as condensing reagents in the synthesis of amides, esters, carboxylic acid anhydrides, peptides and their esters.
 


Ansprüche

1. Quaternäre Ammoniumsalzen N-(3,5-disubstituiert-2,4,6-triazinyl-1)- der Sulfonsäuren aus der Formel 1,

wo R1 und R2 unabhängig von einander ein Halogenatom, eine Alkylgruppe, eine substituierte Alkylgruppe, eine Alkoxylgruppe, eine substituierte Alkoxylgruppe, eine Cycloalkoxyl-Gruppe, eine substituierte Cycloalkoxyl-Gruppe, eine Arylgruppe, eine substituierte Arylgruppe, eine Aryloxygruppe, eine substituierte Aryloxygruppe, eine heterozyklische Gruppe oder eine substituierte heterozyklische Gruppe bezeichnen wo R2, R4, R5 unabhängig von einander eine Alkylgruppe, eine substituierte Alkylgruppe, eine Cycloalkyl-Gruppe, eine substituierte Cycloalkyl-Gruppe, eine Arylgruppe, eine substituierte Arylgruppe, eine heterozyklische Gruppe oder eine substituierte heterozyklische Gruppe bezeichnen oder einen unsubstituierten heterozyklischen Ring zusammen mit dem Stickstoffatom bilden, wobei O-SO2R6 einen Benzolsulfonat-, p-toluensulfonat-, p-Bromobenzolsulfonat-, Chlorobenzolsulfonat-, Methansulfonat-Anion oder einen Amidosulfonat-Anion bezeichnet.
 
2. Die Salzen mit der Formel 1, wie in Anspruch 1, charakterisieren sich dadurch, dass R1 i R2 die Metoxylgruppe bezeichnen.
 
3. Die Benutzung der Verbindungen aus dem Anspruch 1 als kondensierende Reagens in der Synthese von Amiden, Ester, Carbonsäure-Anhydriden, Peptidbindungen und deren Ester.
 


Revendications

1. Les seuls quaternaires N-(3,5 disubstitués-2,4,6-triazinylo-1)-ammonium des acides sulfoniques de la formule 1,

où R1 et R2 désignent indépendamment un atome d'halogène, un groupe alcoylique, un groupe alcoylique substitué, un groupe cycloalcoxilique, un groupe cycloalcoxilique substitué, un groupe arylique, un groupe arylique substitué, un groupe aryloxilique, un groupe aryloxilique substitué, un groupe hétérocyclique ou un groupe hétérocyclique substitué, R2, R4, R5 désignent indépendamment un groupe cycloalcoylique, un groupe cycloalcoylique substitué, un groupe arylique, un groupe arylique substitué, un groupe hétérocyclique ou un groupe hétérocyclique substitué ou ils forment un noyau hétérocyclique non substitué avec des atomes de l'azote, pendant que O-SO2R6 désigne un anion benzenosulfonate, p-tolouenosulfonate, p-bromobenzenosulfonate, chlorobenzenosulfonate, méthanosulfonate ou amidosulfonate.
 
2. Les seuls ayant la formule 1, comme constatés à la revendication, se caractérisent par la présence du groupe méthoxylique dans les positions R1 et R2.
 
3. L'utilisation des composés de la revendication 1 comme des réactifs condensant dans la synthèse des amides, des esters, des anhidrites de l'acide carboxylique, des protéines et de leurs esters.
 




Drawing








Cited references

REFERENCES CITED IN THE DESCRIPTION



This list of references cited by the applicant is for the reader's convenience only. It does not form part of the European patent document. Even though great care has been taken in compiling the references, errors or omissions cannot be excluded and the EPO disclaims all liability in this regard.

Non-patent literature cited in the description